CYB704 (ocelizumab biosimilar candidate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CYB704 (ocelizumab biosimilar candidate), covering 2026-04-27 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis [Phase 3]